Markt geschlossen -
Andere Börsenplätze
|
Nachbörslich 21:58:00 | |||
31.9 EUR | +0.31% | 32.1 | +0.63% |
04.04. | Berenberg belässt Dermapharm auf 'Buy' - Ziel 58 Euro | DP |
28.03. | Dermapharm Holding SE berichtet über die Ergebnisse für das Geschäftsjahr zum 31. Dezember 2023 | CI |
Kurzporträt
Mitarbeiterzahl: 3 497
Umsatz nach Geschäftsbereich
EUR in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Branded Medicine
46,9
%
| - | - | 533 | 46,9 % | - |
Other Health Products
32,7
%
| - | - | 372 | 32,7 % | - |
Parallel Import
20,3
%
| 253 | 24,7 % | 231 | 20,3 % | -8.92% |
Umsatz je Region
EUR in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Germany
62,3
%
| 1 025 | 100,0 % | 707 | 62,3 % | -31.01% |
France
13,4
%
| - | - | 152 | 13,4 % | - |
Spain
10,4
%
| - | - | 118 | 10,4 % | - |
Other
7,9
%
| - | - | 90 | 7,9 % | - |
Austria / Switzerland
6,0
%
| - | - | 69 | 6,0 % | - |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Chief Executive Officer | 61 | 01.08.17 | |
Director of Finance/CFO | - | 01.11.22 | |
Britta Hamberger
IRC | Investor Relations Contact | - | 01.12.18 |
Andreas Eberhorn
SAM | Sales & Marketing | 49 | 01.09.22 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Director/Board Member | 75 | 01.01.18 | |
Wilhelm Beier
CHM | Chairman | 68 | 01.08.17 |
Erwin Kern
BRD | Director/Board Member | 63 | 01.08.17 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 53 840 000 | 17 368 784 ( 32,26 %) | 0 | 32,26 % |
Unternehmenskontakt
Konzerngesellschaften
Name | Kategorie und Branche |
---|---|
Strathmann GmbH & Co. KG
Strathmann GmbH & Co. KG Pharmaceuticals: MajorHealth Technology Strathmann GmbH & Co. KG engages in the manufacture and distribution of pharmaceutical products. It offers muscle relaxants, dermatics, analgesics and anti-inflammatory drugs, antirheumatics, mineral preparations, osteoporosis agents and vaccines, as well as immunomodulators. The company was founded by Detlef Strathmann in 1974 and is headquartered in Hamburg, Germany. |
Pharmaceuticals: Major
|
Dermapharm AG (Switzerland)
| |
Euromed SA (Spain)
Euromed SA (Spain) Pharmaceuticals: OtherHealth Technology Euromed SA engages in the production of herbal extracts and natural active substances. It offers artichoke, echinacea, ginseng, hawthorn, nettle, milk thistle, and valerian products. The firm specializes in pharmaceutical, health, food, and cosmetic industries. The company was founded on July 13, 1971 and is headquartered in Mollet del Valles, Spain. |
Pharmaceuticals: Other
|
Allergopharma AG
Allergopharma AG Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Allergopharma AG is a Swiss company that manufactures and distributes hypoallergenic immunotherapy products. The private company is located in Switzerland. |
Pharmaceuticals: Major
|
Sektor
Umsatz nach Geschäftsbereich
Umsatz je Region
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-24.89% | 1.83 Mrd. | |
+27.97% | 672 Mrd. | |
+23.33% | 550 Mrd. | |
-7.02% | 351 Mrd. | |
+14.85% | 317 Mrd. | |
+6.25% | 292 Mrd. | |
+2.25% | 211 Mrd. | |
-1.00% | 203 Mrd. | |
-10.51% | 194 Mrd. | |
-11.81% | 144 Mrd. |
- Börse
- Aktien
- A2GS5D Aktie
- Unternehmen Dermapharm Holding SE